Apixaban Monitoring: The Jury Is Still Out

Michael W. Rich

doi:10.1016/j.jacadv.2022.100038

Apixaban Monitoring: The Jury Is Still Out

Research output: Contribution to journal › Editorial

Original language	English
Article number	100038
Journal	JACC: Advances
Volume	1
Issue number	2
DOIs	https://doi.org/10.1016/j.jacadv.2022.100038
State	Published - Jun 2022

Keywords

DOAC monitoring
anticoagulants
apixaban
atrial fibrillation
geriatric cardiology

Access to Document

10.1016/j.jacadv.2022.100038

Cite this

@article{760d05e40032429c8ce528b9a27b3204,

title = "Apixaban Monitoring: The Jury Is Still Out",

keywords = "DOAC monitoring, anticoagulants, apixaban, atrial fibrillation, geriatric cardiology",

author = "Rich, {Michael W.}",

year = "2022",

month = jun,

doi = "10.1016/j.jacadv.2022.100038",

language = "English",

volume = "1",

journal = "JACC: Advances",

issn = "2772-963X",

number = "2",

}

TY - JOUR

T1 - Apixaban Monitoring

T2 - The Jury Is Still Out

AU - Rich, Michael W.

PY - 2022/6

Y1 - 2022/6

KW - DOAC monitoring

KW - anticoagulants

KW - apixaban

KW - atrial fibrillation

KW - geriatric cardiology

UR - http://www.scopus.com/inward/record.url?scp=85180185012&partnerID=8YFLogxK

U2 - 10.1016/j.jacadv.2022.100038

DO - 10.1016/j.jacadv.2022.100038

M3 - Editorial

AN - SCOPUS:85180185012

SN - 2772-963X

VL - 1

JO - JACC: Advances

JF - JACC: Advances

IS - 2

M1 - 100038

ER -

Apixaban Monitoring: The Jury Is Still Out

Keywords

Access to Document

Other files and links

Cite this